AKT1 and neoplasm: Our results indicated that GSK3B, a key effector within the PI3K‐Akt pathway, underwent a switch from compartment B to A and was upregulated in somatotroph tumour (Figure 2F, Log2FC 2.22, padj < .001; Table S4).